Within Range: Demystifying Diabetes Tech Blog for Healthcare Providers
A Smarter Way to Support Personalised Insulin Delivery
For many people living with diabetes, particularly children and young people, mealtimes present a daily challenge. Whether it's navigating carbohydrate counting or facing complex dosing calculations, these tasks can feel overwhelming
Gave People With T1D More Than Five Extra Hours In Range Per Day
A direct switch from MDI to the Omnipod 5 AID (automated insulin delivery; hybrid closed-loop) System produced clinically significant glucose improvements within 13 weeks, signalling a practical leap forward in improved
As a healthcare professional, you understand that diabetes management needs vary significantly from patient to patient. Each individual’s journey with diabetes requires a tailored approach to ensure optimal outcomes, and finding the right insulin delivery method is a crucial part of that process
Categories
As a healthcare professional, you understand that diabetes management needs vary significantly from patient to patient.
Every week, clinicians field the same questions from people considering pump therapy: “how will a tubeless insulin pump work in my daily life?”, “what training will I need?”, “how quickly can I get started?”.
Reducing the Burden of Multiple Daily Injections (MDI): Strategies, Support, and Advancing Technologies
MDI remains a widely used approach to insulin delivery in type 1 diabetes (T1D) management.1 MDI involves a complex regimen of bolus and basal injections, typically ≥3 bolus and 1
Why Line-of-Sight Between Pod and CGM Sensor is Crucial
In automated insulin delivery (AID) (also known as hybrid closed-loop) systems, reliable connectivity between continuous glucose monitor (CGM) sensors and the insulin delivery device is essential.
Real-World Data Supports Omnipod 5 Automated Insulin Delivery System for Improved Glycaemic Outcomes1
Evidence from the 2023 real-world study by Marks BE, et al. highlights the significant impact the Omnipod 5 Automated In
The Omnipod 5 Automated Insulin Delivery (AID) System is a transformative step in diabetes care. The system merges the benefits and simplicity of a wearable, tubeless design with AID technology.
Managing type 1 diabetes has never been more innovative and personalised, thanks to advancements in automated insulin delivery (AID) systems.
When making treatment decisions for type 1 diabetes (T1D), healthcare professionals increasingly rely on real-world data to understand how therapies perform outside of clinical trials. A recent study— Aleppo G et al. Diabetes Ther. 2023.
Helping people with type 1 diabetes (T1D) stay active has long been a balancing act. Exercise can improve metabolic health and quality of life but also increases the risk of glycaemic variability and hypoglycaemia.1,2
Managing diabetes is a complex and often overwhelming task for patients. As their healthcare provider, you already know that the right insulin management system can greatly improve both adherence and quality of life.